美国 · SEC FORM 4
Amneal Pharmaceuticals, Inc.
AMRX · Nasdaq · CIK 0001723128 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
23 同一窗口内观察到的 Form 4 交易行
5 sales · 18 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2021-12-17 · Patel Gautam.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +12.4%
- 3M
- +20.0%
- 6M
- +62.7%
- 12M
- —
波动率与流动性
- 波动率
- 35.8%
- Beta
- 1.24
- 平均每日成交额
- USD 43.6M
估值
- 市值
- USD 7.1B
- P/E
- 42.3×
基本面
- 利润率
- 2.4%
- ROE
- 613.0%
- 细分行业
- Drug Manufacturers—Specialty & Generic
市场数据
价格数据截至：2026-10-03 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率 · 财年截止日：2025-12-31 · 来自 Yahoo Finance：市值, P/E, ROE · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 11,278,967
- 上期报告
- 11,289,778
- 日均成交量
- 3,689,288
- 回补天数
- 3.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2021-12-17 | Patel Gautam | 买入 (P) | Class A Common Stock | 50,000 | USD 4.21 | USD 210,500 | SEC 申报 ↗ |
| 2021-12-16 | Patel Chirag K. | 买入 (P) | Class A Common Stock | 50,000 | USD 4.25 | USD 212,500 | SEC 申报 ↗ |
| 2021-12-16 | Patel Chintu | 买入 (P) | Class A Common Stock | 50,000 | USD 4.25 | USD 212,500 | SEC 申报 ↗ |
| 2021-12-15 | Patel Chirag K. | 买入 (P) | Class A Common Stock | 100,000 | USD 4.13 | USD 413,000 | SEC 申报 ↗ |
| 2021-12-15 | Patel Chintu | 买入 (P) | Class A Common Stock | 100,000 | USD 4.13 | USD 413,000 | SEC 申报 ↗ |
| 2020-05-19 | Kiely John | 买入 (P) | Class A Common Stock | 10,000 | USD 4.40 | USD 44,000 | SEC 申报 ↗ |
| 2020-05-15 | George Jeffrey P. | 买入 (P) | Class A Common Stock | 23,810 | USD 4.16 | USD 99,050 | SEC 申报 ↗ |
| 2020-03-18 | MEISTER PAUL M | 买入 (P) | Class A Common Stock | 204,210 | USD 2.71 | USD 553,409 | SEC 申报 ↗ |
| 2020-03-17 | MEISTER PAUL M | 买入 (P) | Class A Common Stock | 149,439 | USD 2.79 | USD 416,935 | SEC 申报 ↗ |
| 2020-03-10 | Patel Chirag K. | 买入 (P) | Class A Common Stock | 100,000 | USD 3.09 | USD 309,000 | SEC 申报 ↗ |
| 2020-03-10 | Patel Chintu | 买入 (P) | Class A Common Stock | 100,000 | USD 3.09 | USD 309,000 | SEC 申报 ↗ |
| 2020-03-04 | Patel Chirag K. | 买入 (P) | Class A Common Stock | 58,938 | USD 3.97 | USD 233,984 | SEC 申报 ↗ |
| 2020-03-04 | Patel Chintu | 买入 (P) | Class A Common Stock | 58,765 | USD 3.97 | USD 233,297 | SEC 申报 ↗ |
| 2020-03-03 | Patel Gautam | 买入 (P) | Class A Common Stock | 117,889 | USD 3.94 | USD 464,483 | SEC 申报 ↗ |
| 2020-03-03 | Patel Chirag K. | 买入 (P) | Class A Common Stock | 156,421 | USD 3.88 | USD 606,913 | SEC 申报 ↗ |
Form 4 申报证据
79 transaction lines in the latest 365-day window; 376 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | BUCHI J KEVIN | 赠与 (G) | Class A Common Stock | 20,445 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | BUCHI J KEVIN | 期权行权／转换 (M) | Class A Common Stock | 20,445 | USD 14.45 | USD 295,430 | SEC 申报 ↗ |
| 2026-09-01 | BOYER ANDREW S | 赠与 (G) | Class A Common Stock | 80,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | BUCHI J KEVIN | 赠与 (G) | Class A Common Stock | 20,445 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-11 | BUCHI J KEVIN | 期权行权／转换 (M) | Class A Common Stock | 20,445 | USD 14.45 | USD 295,430 | SEC 申报 ↗ |
| 2026-09-01 | BOYER ANDREW S | 赠与 (G) | Class A Common Stock | 80,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-21 | BOYER ANDREW S | 赠与 (G) | Class A Common Stock | 152,426 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-13 | Kiely John | 卖出 (S) | Class A Common Stock | 50,000 | USD 17.64 | USD 882,000 | SEC 申报 ↗ |
| 2026-08-13 | Kiely John | 赠与 (G) | Class A Common Stock | 10,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Shah Nikita | 卖出 (S) | Class A Common Stock | 146,403 | USD 17.51 | USD 2,563,517 | SEC 申报 ↗ |
| 2026-08-12 | Daly Jason B. | 卖出 (S) | Class A Common Stock | 210,000 | USD 17.40 | USD 3,654,000 | SEC 申报 ↗ |
| 2026-08-11 | Daly Jason B. | 卖出 (S) | Class A Common Stock | 6,613 | USD 17.70 | USD 117,050 | SEC 申报 ↗ |
| 2026-08-11 | BUCHI J KEVIN | 期权行权／转换 (M) | Class A Common Stock | 168,573 | USD 17.18 | USD 2,896,084 | SEC 申报 ↗ |
| 2026-08-10 | Patel Tushar Bhikhubhai | 奖励／授予 (A) | Class A Common Stock | 12,763,469 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-10 | Patel Gautam | 奖励／授予 (A) | Class A Common Stock | 283,632 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-10 | Patel Chirag K. | 奖励／授予 (A) | Class A Common Stock | 6,381,734 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-10 | Patel Chintu | 奖励／授予 (A) | Class A Common Stock | 6,381,734 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-11 | Autor Deborah M. | 卖出 (S) | Class A Common Stock | 34,819 | USD 12.94 | USD 450,558 | SEC 申报 ↗ |
| 2026-05-07 | Yanai Shlomo | 期权行权／转换 (M) | Class A Common Stock | 34,819 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-07 | Patel Gautam | 期权行权／转换 (M) | Class A Common Stock | 34,819 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-07 | Nark Ted C | 期权行权／转换 (M) | Class A Common Stock | 34,819 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-07 | MEISTER PAUL M | 期权行权／转换 (M) | Class A Common Stock | 48,747 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-07 | Kiely John | 期权行权／转换 (M) | Class A Common Stock | 34,819 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-07 | George Jeffrey P. | 期权行权／转换 (M) | Class A Common Stock | 34,819 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-07 | BUCHI J KEVIN | 期权行权／转换 (M) | Class A Common Stock | 34,819 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-07 | Autor Deborah M. | 期权行权／转换 (M) | Class A Common Stock | 34,819 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-04 | Shah Nikita | 期权行权／转换 (M) | Class A Common Stock | 35,880 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-04 | Shah Nikita | 代扣税 (F) | Class A Common Stock | 17,976 | USD 13.30 | USD 239,081 | SEC 申报 ↗ |
| 2026-03-04 | Patel Chirag K. | 期权行权／转换 (M) | Class A Common Stock | 92,593 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-04 | Patel Chirag K. | 代扣税 (F) | Class A Common Stock | 37,825 | USD 13.30 | USD 503,072 | SEC 申报 ↗ |
| 2026-03-04 | Patel Chintu | 期权行权／转换 (M) | Class A Common Stock | 92,593 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-04 | Patel Chintu | 代扣税 (F) | Class A Common Stock | 28,983 | USD 13.30 | USD 385,474 | SEC 申报 ↗ |
| 2026-03-04 | Konidaris Tasos | 期权行权／转换 (M) | Class A Common Stock | 43,982 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | AMRX |
| CIK | 0001723128 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 376 transaction lines from 2020-01-03 to 2026-09-17 20 P purchase lines · 51 S sale lines · 305 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.